Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 1;29(4):277-284.
doi: 10.1097/MCP.0000000000000968. Epub 2023 May 9.

Telemedicine and remote monitoring in cystic fibrosis

Claire Edmondson  1 , Noah Lechtzin  2
Affiliations
Review

Telemedicine and remote monitoring in cystic fibrosis

Claire Edmondson et al. Curr Opin Pulm Med. .

Abstract

Purpose of review: Guidelines for cystic fibrosis (CF) care recommend multidisciplinary teams see patients at least quarterly with frequent measurement of spirometry and collection of respiratory cultures. This can be burdensome for people with CF, particularly if they live far from a specialized care center. This has led to an interest in telehealth coupled with remote monitoring. We review the recent literature on these topics for people with CF.

Recent findings: The COVID-19 pandemic accelerated a move toward remote delivery of CF care and multiple recent publications have reported on the feasibility of telehealth, remote spirometry, remote collection of respiratory cultures, adherence monitoring, cough assessment, symptom monitoring and activity tracking. Useful data can be obtained and both clinicians and patients have favorable opinions about remote delivery of healthcare, though the impact on clinical outcomes is not yet known.

Summary: Telehealth and remote monitoring for people with CF is feasible and has grown in use, though it is too early to know how prominently these approaches will fit into routine care for CF.

PubMed Disclaimer

References

    1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373:1891–1904.
    1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2020 Annual Data Report. Bethesda, MD; 2021.
    1. Middleton PG, Mall MA, Drevinek P, et al. Group VXS. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 2019; 381:1809–1819.
    1. Ramsey BW, Davies J, McElvaney NG, et al. Group VXS. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365:1663–1672.
    1. Flume PA, O'Sullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176:957–969.

Publication types